Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
about
Advances in Primary Central Nervous System Lymphoma.Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective studyCentral nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.Recent advances in treatment of primary central nervous system lymphoma.Methotrexate re-challenge for recurrent primary central nervous system lymphomaManagement of elderly patients with primary central nervous system lymphoma.Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma.Recurrent or refractory primary central nervous lymphoma: therapeutic considerations.Present and future treatment options for primary CNS lymphoma.Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.Primary central nervous system lymphoma: essential points in diagnosis and management.High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group.Immunochemotherapy using rituximab (RTX) and high-dose methotrexate (HD-MTX): an evaluation of the addition of RTX to HD-MTX in recurrent primary central nervous system lymphoma (PCNSL).Primary CNS Lymphoma.The Diagnosis and Treatment of Primary CNS LymphomaRapid infusion rituximab is well tolerated in patients with primary CNS lymphoma
P2860
Q31007237-6106FD0E-84DD-4BF9-B9DC-83DDB1B754C8Q33714119-65FD448F-79E8-499E-9F93-811DC2233234Q33824350-2FCD43E6-0B59-4634-BB20-8B4BBD272D3FQ37345440-64C60175-CA2D-4246-AE8F-5C37DE2E4F66Q37600487-8055812D-9A45-4164-A3A7-B38C7932FC68Q38096927-6D4FC75F-09A4-4CC4-84DA-D58D69553A84Q38119420-1AEED53C-2A34-460F-BAA0-6EE7DB4F0ED9Q38140000-4F14F6CC-0052-497B-A7CE-A589B355BEBDQ38587122-B462A758-D14D-4B6B-A08C-804BAEB10CBAQ38723290-6D65799D-0C41-46D0-88FE-F2DE161EBAD8Q39185721-D3CC38C0-22E2-4AD7-9509-CB80F2E2CA54Q40179899-CD5D3DE0-87A6-45D3-9DDF-F679248F3AFAQ47692369-D19BB745-7E23-48FC-95D9-FB656D7F12B1Q51841565-4279BE8E-BF3C-443E-B58B-007AF872771AQ56967801-EDBE476E-8694-48DD-A602-D74D3DCC2964Q58728525-E9D21E7E-96AA-4F22-B2B9-7F5210778D7E
P2860
Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Multicenter phase II study of ...... ntral nervous system lymphoma.
@ast
Multicenter phase II study of ...... ntral nervous system lymphoma.
@en
type
label
Multicenter phase II study of ...... ntral nervous system lymphoma.
@ast
Multicenter phase II study of ...... ntral nervous system lymphoma.
@en
prefLabel
Multicenter phase II study of ...... ntral nervous system lymphoma.
@ast
Multicenter phase II study of ...... ntral nervous system lymphoma.
@en
P2093
P2860
P1433
P1476
Multicenter phase II study of ...... ntral nervous system lymphoma.
@en
P2093
Antonio Omuro
Jan Drappatz
Lakshmi Nayak
Lauren E Abrey
Lisa M Deangelis
Mark R Gilbert
Michael Prados
North American Brain Tumor Consortium
Patrick Y Wen
P2860
P356
10.3109/10428194.2012.698736
P577
2012-07-09T00:00:00Z